Examining Access to Primary Care for People With Opioid Use Disorder in Ontario, Canada: A Randomized Clinical Trial.
Journal
JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235
Informations de publication
Date de publication:
01 09 2022
01 09 2022
Historique:
entrez:
30
9
2022
pubmed:
1
10
2022
medline:
5
10
2022
Statut:
epublish
Résumé
People with opioid use disorder are less likely than others to have a primary care physician. To determine if family physicians are less likely to accept people with opioid use disorder as new patients than people with diabetes. This randomized clinical trial used an audit design to survey new patient intake at randomly selected family physicians in Ontario, Canada. Eligible physicians were independent practitioners allowed to prescribe opioids who were located in an office within 50 km of a population center greater than 20 000 people. A patient actor made unannounced telephone calls to family physicians asking for a new patient appointment. The data were analyzed in September 2021. In the first randomly assigned scenario, the patient actor played a role of patient with diabetes in treatment with an endocrinologist. In the second scenario, the patient actor played a role of a patient with opioid use disorder undergoing methadone treatment with an addiction physician. Total offers of a new patient appointment; a secondary analysis compared the proportions of patients offered an appointment stratified by gender, population, model of care, and years in practice. Of a total 383 family physicians included in analysis, a greater proportion offered a new patient appointment to a patient with diabetes (21 of 185 physicians [11.4%]) than with opioid use disorder (8 of 198 physicians [4.0%]) (absolute difference, 7.4%; 95% CI, 2.0 to 12.6; P = .007). Physicians with more than 20 years in practice were almost 13 times less likely to offer an appointment to a patient with opioid use disorder compared with diabetes (1 of 108 physicians [0.9%] vs 10 of 84 physicians [11.9%]; absolute difference, 11.0; 95% CI, 3.8 to 18.1; P = .001). Women were almost 5 times less likely (3 of 111 physicians [2.7%] vs 14 of 114 physicians [12.3%]; absolute difference, 9.6%; 95% CI, 2.4 to 16.3; P = .007) to offer an appointment to a patient with opioid use disorder than with diabetes. In this randomized clinical trial, family physicians were less likely to offer a new patient appointment to a patient with opioid use disorder compared with a patient with diabetes. Potential health system solutions to this disparity include strengthening policies for accepting new patients, improved compensation, and clinician anti-oppression training. ClinicalTrials.gov Identifier: NCT05484609.
Identifiants
pubmed: 36178686
pii: 2796854
doi: 10.1001/jamanetworkopen.2022.33659
pmc: PMC9526081
doi:
Substances chimiques
Methadone
UC6VBE7V1Z
Banques de données
ClinicalTrials.gov
['NCT05484609']
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2233659Références
Scientifica (Cairo). 2012;2012:432892
pubmed: 24278694
Addiction. 2020 Aug;115(8):1482-1493
pubmed: 31899565
CMAJ. 2015 Nov 17;187(17):E494-E502
pubmed: 26391722
Subst Abus. 2017 Apr-Jun;38(2):141-144
pubmed: 28394732
Ann Fam Med. 2011 Mar-Apr;9(2):165-71
pubmed: 21403144
BMC Fam Pract. 2019 Oct 23;20(1):141
pubmed: 31640570
PLoS Med. 2021 Jun 1;18(6):e1003631
pubmed: 34061846
Lancet Psychiatry. 2018 Dec;5(12):987-1012
pubmed: 30392731
Subst Use Misuse. 2009;44(6):794-808
pubmed: 19444722
Can J Psychiatry. 2019 Dec;64(12):872-880
pubmed: 31303027
Can Fam Physician. 2021 Aug;67(8):e227-e234
pubmed: 34385217
Br J Pain. 2015 Nov;9(4):225-32
pubmed: 26526705
J Opioid Manag. 2009 Jan-Feb;5(1):27-37
pubmed: 19344046
Drug Alcohol Rev. 2013 Jul;32(4):426-34
pubmed: 23442133
Can Fam Physician. 2021 Dec;67(12):e348-e354
pubmed: 34906953
BMC Fam Pract. 2012 Jul 16;13:69
pubmed: 22799280
BMC Med Ethics. 2017 Mar 1;18(1):19
pubmed: 28249596
Milbank Q. 2005;83(3):457-502
pubmed: 16202000
JAMA Netw Open. 2021 Apr 1;4(4):e214925
pubmed: 33830229
BMC Fam Pract. 2015 Oct 13;16:135
pubmed: 26463083
J Urban Health. 2015 Feb;92(1):193-213
pubmed: 25550126
CMAJ Open. 2020 Jun 19;8(2):E455-E461
pubmed: 32561592
Eur J Health Econ. 2020 Dec;21(9):1279-1293
pubmed: 32676753
Subst Abus. 2019;40(2):207-213
pubmed: 30689528
Drug Alcohol Depend. 2018 Nov 1;192:316-323
pubmed: 30312893
Isr J Health Policy Res. 2018 Aug 27;7(1):49
pubmed: 30145980
Drug Alcohol Depend. 2017 Aug 1;177:315-321
pubmed: 28733101
Ann Fam Med. 2018 Nov;16(6):549-551
pubmed: 30420371
Lancet. 2018 Apr 28;391(10131):1718-1735
pubmed: 29483027
Subst Abus. 2005 Mar;26(1):15-22
pubmed: 16492659
Can Fam Physician. 2019 May;65(5):343-351
pubmed: 31088874
Ann Fam Med. 2016 Nov;14(6):517-525
pubmed: 28376438
Drug Alcohol Depend. 2016 Aug 01;165:61-70
pubmed: 27261154
BMC Health Serv Res. 2020 Nov 23;20(1):1060
pubmed: 33228650
J Am Board Fam Med. 2013 Jul-Aug;26(4):394-400
pubmed: 23833154
JAMA Netw Open. 2019 Jul 3;2(7):e196928
pubmed: 31298712
J Gen Intern Med. 2013 Nov;28(11):1504-10
pubmed: 23576243
Can Fam Physician. 2011 Mar;57(3):324-32
pubmed: 21402971
Psychiatr Serv. 2009 Dec;60(12):1676-9
pubmed: 19952160
J Gen Intern Med. 2020 Aug;35(8):2365-2374
pubmed: 32291723
Br J Gen Pract. 2019 Aug;69(685):e526-e536
pubmed: 31307999
Int J Environ Res Public Health. 2015 Apr 28;12(5):4638-51
pubmed: 25927477
BMJ Open. 2021 Feb 10;11(2):e042865
pubmed: 33568374
Drug Alcohol Depend. 2012 May 1;122(3):241-6
pubmed: 22115887
Health Serv Res. 2007 Apr;42(2):755-72
pubmed: 17362216
Int J Ment Health Addict. 2013 Feb 1;11(1):110-122
pubmed: 23956702
J Psychiatr Ment Health Nurs. 2009 Apr;16(3):279-84
pubmed: 19291157
BMC Health Serv Res. 2020 Sep 7;20(1):837
pubmed: 32894114
CMAJ. 2013 Apr 2;185(6):E263-9
pubmed: 23439620
J Gen Intern Med. 2002 May;17(5):327-33
pubmed: 12047728